Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Innate immune processes in lupus erythematosus.
Aringer M, Günther C, Lee-Kirsch MA. Aringer M, et al. Clin Immunol. 2013 Jun;147(3):216-22. doi: 10.1016/j.clim.2012.11.012. Epub 2012 Dec 12. Clin Immunol. 2013. PMID: 23290784 Review.
[Common German language nomenclature for systemic sclerosis].
Aringer M, Müller-Ladner U, Burkhardt H, Distler JH, Distler O, Graninger WB, Günther C, Hunzelmann N, Kiener H, Sticherling M, Sunderkötter C, Walker UA, Riemekasten G. Aringer M, et al. Z Rheumatol. 2015 Mar;74(2):100-3. doi: 10.1007/s00393-014-1550-5. Z Rheumatol. 2015. PMID: 25805510 German.
[Still's disease in children and adults].
Hedrich CM, Günther C, Aringer M. Hedrich CM, et al. Among authors: aringer m. Hautarzt. 2017 Jun;68(6):497-511. doi: 10.1007/s00105-017-3983-7. Hautarzt. 2017. PMID: 28451698 Review. German.
[Still's disease in children and adults].
Hedrich CM, Günther C, Aringer M. Hedrich CM, et al. Among authors: aringer m. Z Rheumatol. 2017 Sep;76(7):595-608. doi: 10.1007/s00393-017-0358-5. Z Rheumatol. 2017. PMID: 28755070 Review. German.
Janus kinase inhibitors clear to land.
Aringer M. Aringer M. Rheumatology (Oxford). 2018 Jul 1;57(7):1131-1132. doi: 10.1093/rheumatology/kex217. Rheumatology (Oxford). 2018. PMID: 28633283 No abstract available.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.
Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Poór G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D. Smolen JS, et al. Among authors: aringer m. Ann Rheum Dis. 2017 Jun;76(6):960-977. doi: 10.1136/annrheumdis-2016-210715. Epub 2017 Mar 6. Ann Rheum Dis. 2017. PMID: 28264816 Free article. Review.
303 results